Nouveaux antibiotiques pour la clinique : un tour d’horizon [New antibiotics for the clinical setting, an overview]
Fiche du document
15 avril 2020
- doi: 10.53738/REVMED.2020.16.690.0713
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.690.0713
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32301304
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_18A9A4B203173
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
New drug development Drugs--Development Development of drugs Celestial horizon Apparent horizon Real horizon Sensible horizon Global health International health Hours (Time) Organisation People Man Humanity (Human beings) Human race Mankind Homo sapiens Humankind Humans Resistance to drugs Antiinfective agents Antimicrobial agents Antimicrobial drugs AntimicrobialsCiter ce document
S. Meylan et al., « Nouveaux antibiotiques pour la clinique : un tour d’horizon [New antibiotics for the clinical setting, an overview] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.690.0713
Métriques
Partage / Export
Résumé
Antibiotic resistance has become a major medical problem of our time. In 2015, the World Health Organisation (WHO) endorsed a global action plan in response. One of the main axes of this plan has been the sustained development of new antimicrobials. Despite its challenges, over half a dozen new substances have become clinically available in the last decade. Here, we review a selection of these novel antimicrobial and their applications and discuss their possible use in the clinical setting.